• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有II型常染色体显性骨硬化症老年女性患者的基因分析

Genetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.

作者信息

Kim Seon Young, Lee Younghak, Kang Yea Eun, Kim Ji Min, Joung Kyong Hye, Lee Ju Hee, Kim Koon Soon, Kim Hyun Jin, Ku Bon Jeong, Shong Minho, Yi Hyon Seung

机构信息

Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea.

Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.

出版信息

Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.

DOI:10.3803/EnM.2018.33.3.380
PMID:30229577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6145957/
Abstract

BACKGROUND

Type II autosomal dominant osteopetrosis (ADO II) is a rare genetically heterogeneous disorder characterized by osteosclerosis and increased bone mass, predominantly involving spine, pelvis, and skull. It is closely related to functional defect of osteoclasts caused by chloride voltage-gated channel 7 () gene mutations. In this study, we aimed to identify the pathogenic mutation in a Korean patient with ADO II using whole exome sequencing.

METHODS

We evaluated the clinical, biochemical, and radiographic analysis of a 68-year-old woman with ADO II. We also performed whole exome sequencing to identify pathogenic mutation of a rare genetic disorder of the skeleton. Moreover, a polymorphism phenotyping program, Polymorphism Phenotyping v2 (PolyPhen-2), was used to assess the effect of the identified mutation on protein function.

RESULTS

Whole exome sequencing using peripheral leukocytes revealed a heterozygous c.296A>G missense mutation in the gene. The mutation was also confirmed using Sanger sequencing. The mutation c.296A>G was regarded to have a pathogenic effect by PolyPhen-2 software.

CONCLUSION

We detect a heterozygous mutation in gene of a patient with ADO II, which is the first report in Korea. Our present findings suggest that symptoms and signs of ADO II patient having a c.296A>G mutation in may appear at a very late age. The present study would also enrich the database of mutations and improve our understanding of ADO II.

摘要

背景

II型常染色体显性遗传性骨硬化症(ADO II)是一种罕见的遗传性异质性疾病,其特征为骨硬化和骨量增加,主要累及脊柱、骨盆和颅骨。它与氯离子电压门控通道7(CLCN7)基因突变导致的破骨细胞功能缺陷密切相关。在本研究中,我们旨在通过全外显子组测序确定一名韩国ADO II患者的致病突变。

方法

我们对一名68岁的ADO II女性患者进行了临床、生化和影像学分析。我们还进行了全外显子组测序以确定一种罕见骨骼遗传病的致病突变。此外,使用多态性表型分析程序Polymorphism Phenotyping v2(PolyPhen-2)评估所鉴定突变对蛋白质功能的影响。

结果

使用外周血白细胞进行全外显子组测序发现CLCN7基因存在杂合性c.296A>G错义突变。该突变也通过桑格测序得到证实。PolyPhen-2软件认为c.296A>G突变具有致病作用。

结论

我们在一名ADO II患者的CLCN7基因中检测到杂合突变,这是韩国的首例报告。我们目前的研究结果表明,CLCN7基因存在c.296A>G突变的ADO II患者的症状和体征可能在很晚的年龄才出现。本研究还将丰富CLCN7基因突变数据库,并增进我们对ADO II的理解。

相似文献

1
Genetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.一名患有II型常染色体显性骨硬化症老年女性患者的基因分析
Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.
2
Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II).中国常染色体显性遗传性骨硬化症(II型)家系中CLCN7基因的两个新突变
J Bone Miner Metab. 2016 Jul;34(4):440-6. doi: 10.1007/s00774-015-0682-2. Epub 2015 Jun 9.
3
Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients.CLCN7基因的新型突变在中国患者中导致常染色体显性II型骨硬化症(ADO-II)和中间型常染色体隐性骨硬化症(IARO)。
Osteoporos Int. 2016 Mar;27(3):1047-1055. doi: 10.1007/s00198-015-3320-x. Epub 2015 Sep 22.
4
Autosomal dominant osteopetrosis type II resulting from a mutation in the gene: A case report.由该基因突变导致的常染色体显性遗传II型骨硬化症:一例报告。
World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.
5
Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II).两个常染色体显性遗传性骨硬化症(II型)中国家系中CLCN7基因突变的鉴定。
J Bone Miner Metab. 2009;27(4):444-51. doi: 10.1007/s00774-009-0051-0. Epub 2009 Mar 14.
6
Clinical and genetic diagnosis of autosomal dominant osteopetrosis type II in a Chinese family: A case report.一个中国家庭中II型常染色体显性骨硬化症的临床与基因诊断:病例报告
World J Clin Cases. 2023 Jan 26;11(3):700-708. doi: 10.12998/wjcc.v11.i3.700.
7
Novel CLCN7 mutations cause autosomal dominant osteopetrosis type II and intermediate autosomal recessive osteopetrosis.新型 CLCN7 突变导致常染色体显性骨硬化症 II 型和中间型常染色体隐性骨硬化症。
Mol Med Rep. 2019 Jun;19(6):5030-5038. doi: 10.3892/mmr.2019.10123. Epub 2019 Apr 3.
8
Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.常染色体显性遗传性骨硬化症:94例氯离子通道7基因突变患者的临床严重程度及自然病史。
J Clin Endocrinol Metab. 2007 Mar;92(3):771-8. doi: 10.1210/jc.2006-1986. Epub 2006 Dec 12.
9
Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.氯离子通道ClCN7突变是导致严重隐性、显性和中间型骨硬化症的原因。
J Bone Miner Res. 2003 Oct;18(10):1740-7. doi: 10.1359/jbmr.2003.18.10.1740.
10
A Case of Autosomal Dominant Osteopetrosis Type 2 with a Gene Mutation.一例伴有基因突变的常染色体显性2型骨硬化症病例。
J Clin Res Pediatr Endocrinol. 2019 Nov 22;11(4):439-443. doi: 10.4274/jcrpe.galenos.2019.2018.0229. Epub 2019 Feb 14.

引用本文的文献

1
Autosomal dominant osteopetrosis type II resulting from a mutation in the gene: A case report.由该基因突变导致的常染色体显性遗传II型骨硬化症:一例报告。
World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.

本文引用的文献

1
Merck &Co. drops osteoporosis drug odanacatib.默克公司放弃骨质疏松症药物odanacatib。
Nat Rev Drug Discov. 2016 Sep 29;15(10):669. doi: 10.1038/nrd.2016.207.
2
Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients.CLCN7基因的新型突变在中国患者中导致常染色体显性II型骨硬化症(ADO-II)和中间型常染色体隐性骨硬化症(IARO)。
Osteoporos Int. 2016 Mar;27(3):1047-1055. doi: 10.1007/s00198-015-3320-x. Epub 2015 Sep 22.
3
Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II).
中国常染色体显性遗传性骨硬化症(II型)家系中CLCN7基因的两个新突变
J Bone Miner Metab. 2016 Jul;34(4):440-6. doi: 10.1007/s00774-015-0682-2. Epub 2015 Jun 9.
4
Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton.骨硬化症及其与发现骨骼相关新功能的相关性。
Int J Endocrinol. 2015;2015:372156. doi: 10.1155/2015/372156. Epub 2015 Mar 19.
5
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.序列变异解读的标准与指南:美国医学遗传学与基因组学学会和分子病理学协会的联合共识推荐
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
6
Autosomal dominant osteopetrosis revisited: lessons from recent studies.常染色体显性遗传性骨硬化症再认识:来自近期研究的启示。
Eur J Endocrinol. 2013 Jul 13;169(2):R39-57. doi: 10.1530/EJE-13-0136. Print 2013 Aug.
7
Rapid gene identification in a Chinese osteopetrosis family by whole exome sequencing.全外显子组测序快速鉴定中国一家骨硬化症家系的致病基因。
Gene. 2013 Mar 10;516(2):311-5. doi: 10.1016/j.gene.2012.12.072. Epub 2013 Jan 4.
8
Osteopetrosis.骨质石化症
Orphanet J Rare Dis. 2009 Feb 20;4:5. doi: 10.1186/1750-1172-4-5.
9
Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.常染色体显性遗传性骨硬化症:94例氯离子通道7基因突变患者的临床严重程度及自然病史。
J Clin Endocrinol Metab. 2007 Mar;92(3):771-8. doi: 10.1210/jc.2006-1986. Epub 2006 Dec 12.
10
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.49例骨质石化症患者的临床、遗传及细胞分析:对诊断和治疗的意义
J Med Genet. 2006 Apr;43(4):315-25. doi: 10.1136/jmg.2005.036673. Epub 2005 Aug 23.